News

The collaborative research agreement is to undertake the development of a vaccine targeted at preventing cytomegalovirus (CMV) disease the most important preventable infectious disease of unborn children in

The transaction includes an initial upfront payment, future development milestone payments and an undisclosed royalty on potential future products sales. The Genesis F A S T Funnel Catheter

The trial evaluated the safety and efficacy of combining a standard dose of Zevalin followed by high-dose Beam and autologous stem-cell transplantation (ASCT) in patients with non-Hodgkin’s lymphoma

L-DOS47 combines Helix’s proprietary DOS47 new drug candidate with a highly specific single domain antibody to form a potential new targeted drug product for the treatment of adenocarcinoma

The present work performed under a co-operative research and development agreement (CRADA) with the Department of Veteran’s Affairs (VA) demonstrated that inhibition of the enzyme protein kinase C-iota

This project builds on the progress of Galapagos’s July 2006 IWT funded project, where new biological models were developed to evaluate the effectiveness of small molecules to treat

Mark Mirken, president and COO of Millennium Biotechnologies, said: “Our agreement will allow us to use Millennium’s extensive clinical experience and success in the cancer and HIV channels

MRX-4 was nasally administered as a single dose once a week for four consecutive weeks. The first administration was given without a nasal allergen challenge (NAC) while the

Although Merck spokesman Ron Rogers confirmed that a Fosamax-related deal has been signed, he did not divulge details about the deal, maintaining that the details were proprietary. Fosamax’s